Clinical Trial Update: Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation [Phase 3]

View source ↗

Summary

This document reports the results of a Phase 3 trial evaluating the efficacy and safety of clopidogrel in neonates and infants with congenital heart defects req…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Heart Defects, Congenital | Phase 3 | Status: COMPLETED | Results posted: 2011-03-11